Search
Menu
Home
HTB
2019
December
December 2019
Contents
Editorial
i-Base 2019 appeal: we need your help….
HTB 13 December 2019 online
Supplements
Introduction to ART – October 2019
UK Guide to PrEP – November 2019
Conference reports
17th European AIDS Conference (EACS 2019)
Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV
Dolutegravir/lamivudine as dual ART
Weight changes with doravirine-based first line therapy
Bone and renal changes in the ADVANCE trial
10th International Workshop on HIV and Ageing
Impact of isolation and loneliness on older people living with HIV
Antiretrovirals
Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF
Fostemsavir submitted to US FDA for multidrug resistant HIV
Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA
Weight, diabetes, metabolic complications
Tesamorelin for NAFLD in people living with HIV
PDFs
13 December 2019 vol 20 no 14
HTB RSS
Early access
UK guidelines on doxyPEP to prevent syphilis
17 June 2025
APBI calls for greater participant diversity in industry studies
15 June 2025
TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel
6 June 2025
Gates Foundation commits to providing lenacapavir as PrEP next year
3 June 2025
All early access reports
Current issues
June 2025
May 2025
April 2025
Back issues
Special report
APBI calls for greater participant diversity in industry studies
15 June 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate